NCT02555215 - Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

September 24, 2018

Study Completion Date

September 24, 2018

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

dimethyl fumarate

administered orally

Trial Locations (12)

Research Site, Sofia

Research Site, Ghent

Research Site, Kuwait City

Research Site, Göttingen

Research Site, Hradec Králové

Research Site, Munich

Research Site, Loma Linda

Research Site, Riga

Research Site, Beirut

Research Site, Gdansk

Research Site, Poznan

Research Site, Ankara